These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25301674)

  • 1. Weight loss reduces serum monocyte chemoattractant protein-1 concentrations in association with improvements in renal injury in obese men with metabolic syndrome.
    Fu CP; Sheu WH; Lee IT; Lee WJ; Wang JS; Liang KW; Lee WL; Lin SY
    Clin Chem Lab Med; 2015 Mar; 53(4):623-9. PubMed ID: 25301674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men.
    Fu CP; Lee IT; Sheu WH; Lee WJ; Liang KW; Lee WL; Lin SY
    Clin Chim Acta; 2012 Oct; 413(19-20):1647-51. PubMed ID: 22609259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent elevation of paraoxonase-1 specific enzyme activity after weight reduction in obese non-diabetic men with metabolic syndrome.
    Liang KW; Lee WJ; Lee IT; Lee WL; Lin SY; Hsu SL; Wan CJ; Yu CY; Tsai IC; Fu CP; Ting CT; Sheu WH
    Clin Chim Acta; 2011 Sep; 412(19-20):1835-41. PubMed ID: 21704607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.
    Satoh-Asahara N; Suganami T; Majima T; Kotani K; Kato Y; Araki R; Koyama K; Okajima T; Tanabe M; Oishi M; Himeno A; Kono S; Sugawara A; Hattori M; Ogawa Y; Shimatsu A;
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):265-73. PubMed ID: 21051748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
    Kim CS; Park HS; Kawada T; Kim JH; Lim D; Hubbard NE; Kwon BS; Erickson KL; Yu R
    Int J Obes (Lond); 2006 Sep; 30(9):1347-55. PubMed ID: 16534530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte chemoattractant protein-1 gene polymorphism and its serum level have an impact on anthropometric and biochemical risk factors of metabolic syndrome in Indian population.
    Madeshiya AK; Singh S; Dwivedi S; Saini KS; Singh R; Tiwari S; Konwar R; Ghatak A
    Int J Immunogenet; 2015 Apr; 42(2):78-86. PubMed ID: 25639755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men.
    Fu CP; Sheu WH; Lee IT; Tsai IC; Lee WJ; Liang KW; Lee WL; Lin SY
    Clin Chim Acta; 2013 Jun; 421():98-103. PubMed ID: 23499571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dietary restriction on peripheral monoamines and anxiety symptoms in obese subjects with metabolic syndrome.
    Perez-Cornago A; Ramírez MJ; Zulet MÁ; Martinez JA
    Psychoneuroendocrinology; 2014 Sep; 47():98-106. PubMed ID: 25001959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects.
    Christiansen T; Richelsen B; Bruun JM
    Int J Obes (Lond); 2005 Jan; 29(1):146-50. PubMed ID: 15520826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity.
    Schernthaner GH; Kopp HP; Kriwanek S; Krzyzanowska K; Satler M; Koppensteiner R; Schernthaner G
    Obes Surg; 2006 Jun; 16(6):709-15. PubMed ID: 16756729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte chemoattractant protein-1 is related to metabolic syndrome and homocysteine in subjects without clinically significant atherosclerotic cardiovascular disease.
    Kim SH; Lee JW; Im JA; Hwang HJ
    Scand J Clin Lab Invest; 2011 Feb; 71(1):1-6. PubMed ID: 21073393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals.
    Straznicky NE; Grima MT; Lambert EA; Eikelis N; Dawood T; Lambert GW; Nestel PJ; Masuo K; Sari CI; Chopra R; Mariani JA; Schlaich MP
    J Hypertens; 2011 Mar; 29(3):553-64. PubMed ID: 21119532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of monocyte chemoattractant protein-1 -2518 polymorphism with metabolic syndrome in a South Indian cohort.
    Kaur S; Panicker SR; James T; Sarma PS; Thankappan KR; Kartha CC
    Metab Syndr Relat Disord; 2009 Jun; 7(3):193-8. PubMed ID: 19450143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex steroid-induced changes in circulating monocyte chemoattractant protein-1 levels may contribute to metabolic dysfunction in obese men.
    Ruige JB; Bekaert M; Lapauw B; Fiers T; Lehr S; Hartwig S; Herzfeld de Wiza D; Schiller M; Passlack W; Van Nieuwenhove Y; Pattyn P; Cuvelier C; Taes YE; Sell H; Eckel J; Kaufman JM; Ouwens DM
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1187-91. PubMed ID: 22523336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programmes.
    Kelishadi R; Hashemipour M; Mohammadifard N; Alikhassy H; Adeli K
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):721-9. PubMed ID: 18284632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise in pregnancy does not alter gestational weight gain, MCP-1 or leptin in obese women.
    Dekker Nitert M; Barrett HL; Denny KJ; McIntyre HD; Callaway LK;
    Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):27-33. PubMed ID: 25688817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the presence of metabolic syndome influence weight loss in obese and overweight women?
    Evangelou P; Tzotzas T; Christou G; Elisaf MS; Kiortsis DN
    Metab Syndr Relat Disord; 2010 Apr; 8(2):173-8. PubMed ID: 20156072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of weight loss on FABP4 and RBP4 in obese women with metabolic syndrome.
    Comerford KB; Buchan W; Karakas SE
    Horm Metab Res; 2014 Mar; 46(3):224-31. PubMed ID: 23979787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.